sideBackTrevor is a main board director of The Wellcome Foundation where he has been responsible for R&D, including the development of AZT, Zovirax, Lamictal, Malarone and other medicines.

A director of Allergan Inc and Sigma Tau, Trevor has also been a member of the UK Government Regulatory Agency for 12 years and member of the Medicines Commission for 10 years.

In 2004, was appointed to the World Health Organisation Commission on Intellectual Property Rights, Innovation and Public Health and in 2006 was awarded the CBE for services to the pharmaceutical industry.